AZoLifeSciences on MSN3 个月
Scientists Identify Key Role of Proteasome in Cell Death
The team concentrated on the proteasome, which functions as a sort of recycling bin for the cell. Through the operations of ...
GlobalData on MSN3 个月
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception, backed by a $15m investment, to develop a new class of proteasome activator ...
ALZFORUM7 天
C-Terminal Amidation Sends Proteins to the Shredder
C-terminal amidation is a PTM that involves the addition of an amid group to the C-terminus of a peptide or protein. Currently there is no direct evidence to suggest that C-terminal amidation of ...
Pharmabiz7 天
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ...
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...
Daily6 天
Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ...
Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, ...